This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm of soft tissue of retroperitoneum and peritoneum
CD2_BENIGN_RETROPERITONEUM_PERITONEUM_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasma benignum telae mollis spatii retroperitonealis et/sive peritonei
Similar endpoints
↥List of similar endpoints to
Benign neoplasm of soft tissue of retroperitoneum and peritoneum
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of soft tissue of retroperitoneum and peritoneum
- Benign neoplasms
- Benign neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 182 | 132 | 50 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.02 |
| Median age at first event (years) | 55.96 | 52.16 | 66.01 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 176
- Matched controls
- 1761
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D20.0
ICD-10 Finland
Benign neoplasm: Retroperitoneum
+∞
126.9
106
*
D20.1
ICD-10 Finland
Benign neoplasm: Peritoneum
+∞
56.3
51
*
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
+∞
18.0
17
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
21.8
16.0
23
12
WX302
NOMESCO Finland
Thoracal epidural anesthesy
19.7
14.2
21
12
130
Kela drug reimbursment
Malignant tumour
+∞
12.6
12
*
JN4BD
NOMESCO Finland
Extensive body CT
9.0
12.4
26
33
JAH00
NOMESCO Finland
Laparotomy
16.5
11.6
18
12
JAH01
NOMESCO Finland
Laparoscopy
8.8
11.3
24
31
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
10.5
10
*
21170
ICD-8 Finland
Benign neoplasm of other parts of digestive system, Peritoneum and retroperitoneal tissue
+∞
10.5
10
*
115
Kela drug reimbursment
Breast cancer
+∞
10.5
10
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
34.9
10.5
13
*
UJF32
NOMESCO Finland
Coloscopy
3.3
10.5
63
254
H02AB02
ATC
dexamethasone; systemic
16.2
9.7
15
10
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.3
8.9
34
93
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
21.3
8.6
12
6
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
8.6
86
469
D20
ICD-10 Finland
Benign neoplasm of soft tissue of retroperitoneum and peritoneum
+∞
8.4
8
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
UKC02
NOMESCO Finland
Cystoscopy
3.6
8.2
39
130
B01AB05
ATC
enoxaparin; parenteral
2.8
7.9
60
275
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.5
7.3
76
410
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
7.3
7
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
31.4
7.2
9
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.7
7.1
58
275
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
6.9
55
256
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
41.7
6.8
8
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
41.7
6.8
8
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
23.6
6.7
9
*
L02BG04
ATC
letrozole; oral
23.6
6.7
9
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.3
6.6
33
114
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
72.4
6.5
7
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
72.4
6.5
7
*
2118X
ICD-9 Finland
Benign neoplasm of other parts of digestive system, Retroperitoneum and peritoneum[NEOPLASMA BENIGNUM ALIUD SPATII RETROPERITON ET PER]
+∞
6.3
6
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
44
69
8.09
28.36
3.0
1.6
5.7
2.7
ug/l
1.11
33
49
67
288
3.10
11.49
3.1
1.8
—
—
—
0
0
100
587
2.56
8.88
4.6
3.5
—
—
—
0
0
16
33
5.22
7.56
1.4
1.2
117.2
50.8
pmol/l
0.64
16
33
106
697
2.25
6.60
9.0
3.2
11.5
10.8
umol/l
0.39
97
648
112
755
2.26
6.53
10.8
6.4
4.4
4.1
e9/l
0.43
92
646
10
20
5.23
4.83
1.5
1.8
—
—
—
0
0
138
1082
2.14
4.65
11.4
4.6
87.8
75.8
u/l
1.15
129
979
88
591
1.95
4.64
8.6
4.4
1.2
1.2
mmol/l
0.80
80
518
68
426
1.95
4.33
3.5
3.0
1361.7
1440.9
ng/l
0.07
60
349
73
470
1.92
4.28
3.7
2.8
—
—
—
0
0
59
358
1.96
4.09
3.3
2.2
327.5
5942.8
umol/l
1.82
52
308
7
7
10.33
4.04
3.6
3.0
6.6
3.8
nmol/l
—
7
7
9
14
6.70
4.03
1.0
1.0
—
—
—
0
0
23
95
2.63
3.99
3.3
1.7
0.2
0.2
g/l
0.05
23
84
40
215
2.10
3.85
2.9
2.6
3.3
2.7
e6/l
0.19
26
115
19
74
2.75
3.68
1.4
1.3
—
—
—
0
0
53
322
1.91
3.61
1.7
1.7
1.0
1.0
mg/l
0.08
40
256
91
657
1.77
3.52
8.9
4.5
1.2
1.2
mmol/l
0.59
80
557
6
6
10.28
3.52
3.3
2.2
—
—
—
0
0
6
7
8.81
3.28
1.2
1.6
—
—
—
0
0
55
348
1.83
3.27
2.6
2.0
2.7
2.9
mg/l
0.39
48
290
134
1097
1.84
3.25
5.3
3.8
15.0
12.1
mm/h
1.12
124
993
26
126
2.24
3.22
6.3
6.3
0.4
1.8
mmol/l
0.99
20
104
39
224
1.94
3.11
2.7
2.4
0.7
1.1
e6/l
0.72
24
123
18
78
2.45
2.85
1.5
1.4
—
—
—
0
0
12
43
2.92
2.70
1.5
1.2
1.3
0.0
g/l
0.62
12
38
7
17
4.24
2.38
1.9
1.2
—
—
—
0
0
76
569
1.58
2.30
4.4
3.5
55.6
39.9
ng/l
0.28
53
376
13
54
2.52
2.25
1.5
1.3
—
—
—
0
0
5
9
5.67
2.22
3.2
1.3
—
—
—
0
0
8
24
3.44
2.21
1.8
1.3
—
—
—
0
0
8
25
3.30
2.12
1.6
1.2
—
—
—
0
0
5
10
5.11
2.08
3.2
1.3
—
—
—
0
0
32
197
1.76
2.04
3.9
4.7
33.4
32.8
%
0.11
25
122
8
26
3.17
2.04
1.8
1.2
—
—
—
0
0
52
365
1.59
2.03
4.1
2.8
0.7
0.3
e6/l
0.44
38
263
22
121
1.93
1.99
9.7
2.9
248.3
235.9
u/l
0.30
22
113
17
87
2.05
1.87
3.4
2.8
5.2
5.1
kpa
0.14
17
77
114
963
1.49
1.82
4.7
2.9
62.0
40.4
u/l
1.01
107
901
11
47
2.43
1.81
1.5
1.2
10.0
10.5
g/l
0.22
11
39
30
190
1.69
1.74
2.1
1.7
—
—
—
0
0
45
317
1.56
1.72
2.0
1.7
257500425.9
456.0
pmol/l
0.49
40
256
10
42
2.46
1.71
1.6
1.2
39.5
38.6
g/l
—
10
33
8
31
2.65
1.68
1.1
1.1
—
—
—
0
0
8
32
2.57
1.61
1.5
1.2
—
—
—
0
0
40
279
1.56
1.59
1.2
1.3
13.0
40.5
iu/ml
2.68
11
86
37
258
1.54
1.47
2.3
2.1
2.5
2.4
mmol/l
0.38
32
218
5
16
3.18
1.44
1.8
1.1
—
—
—
0
0
5
16
3.18
1.44
1.8
1.1
—
—
—
0
0
5
16
3.18
1.44
1.8
1.1
—
—
—
0
0
5
16
3.18
1.44
1.8
1.1
—
—
—
0
0
5
16
3.18
1.44
1.8
1.1
—
—
—
0
0
5
16
3.18
1.44
1.8
1.1
—
—
—
0
0
158
1459
1.63
1.42
22.5
11.0
25.4
20.6
mg/l
1.09
140
1113
14
75
1.94
1.38
1.7
1.5
—
—
—
0
0
10
47
2.19
1.36
1.7
1.7
—
—
—
0
0
0
40
0.00
1.34
0.0
2.9
—
106.9
—
0
30
86
720
1.37
1.28
4.0
3.6
0.0
0.0
estimate
0.00
13
111
43
319
1.46
1.28
1.3
1.3
0.6
2.1
u/ml
1.36
12
81
10
51
2.02
1.13
2.2
1.8
—
—
—
0
0
27
187
1.52
1.12
8.6
6.4
—
—
—
0
0
47
364
1.39
1.10
1.9
1.5
19.8
22.5
nmol/l
0.60
42
301
11
59
1.92
1.10
2.9
2.2
0.9
1.0
%
0.26
11
59
84
714
1.33
1.09
5.5
5.0
0.0
0.0
estimate
0.00
13
115
128
1157
1.36
1.08
5.1
4.0
14.9
14.7
pmol/l
0.53
117
1049
7
33
2.16
1.07
2.3
1.3
25.5
25.9
mg/l
—
7
28
7
33
2.16
1.07
2.3
1.3
151.2
42.5
mg/l
—
7
28
20
131
1.59
1.05
2.1
1.7
—
—
—
0
0
35
261
1.42
1.02
1.2
1.3
3.7
14.1
u/ml
1.43
19
90
18
116
1.61
1.01
2.7
2.0
72.3
66.5
ml/min/173m2
—
6
46
72
606
1.31
0.98
3.3
2.2
80.9
79.4
nmol/l
0.17
64
525
148
1378
1.40
0.96
19.4
10.4
76.8
79.1
ml/min/173m2
0.56
127
1084
7
129
0.52
0.92
1.3
1.8
—
—
—
0
0
27
196
1.44
0.91
3.5
1.6
27.3
29.4
s
2.07
27
188
73
623
1.29
0.88
2.3
2.0
105.3
97.6
pmol/l
0.44
38
289
19
134
1.47
0.75
3.9
3.0
—
—
—
0
0
147
1385
1.32
0.73
6.1
4.9
2.1
1.9
mu/l
0.34
137
1262
5
25
2.03
0.73
2.6
3.1
—
25.2
—
0
6
7
44
1.61
0.66
2.4
1.6
—
—
—
0
0
13
186
0.68
0.63
3.3
3.7
20.9
24.3
%
—
5
91
18
134
1.38
0.55
2.2
1.7
—
—
—
0
0
79
713
1.19
0.52
4.0
3.6
0.0
0.0
estimate
0.00
12
123
10
68
1.50
0.48
1.3
1.7
—
—
—
0
0
37
313
1.23
0.47
4.2
3.5
333.1
85.7
ng/l
0.53
32
243
21
262
0.78
0.46
1.7
1.5
—
—
—
0
0
95
879
1.17
0.45
3.4
3.0
—
—
—
0
0
5
32
1.58
0.42
1.4
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
8
60
1.35
0.41
1.5
1.4
—
—
—
0
0
5
34
1.48
0.40
1.0
1.1
—
—
—
0
0
34
291
1.21
0.39
2.2
1.7
1219.4
1175.8
nmol/l
0.09
24
209
137
1317
1.16
0.35
21.5
13.0
38.6
39.8
%
1.28
94
936
7
54
1.31
0.31
1.4
1.5
—
—
—
0
0
8
63
1.28
0.28
2.3
2.1
38.0
44.9
u/l
—
8
54
25
288
0.85
0.28
1.3
1.4
—
—
—
0
0
11
138
0.78
0.26
1.5
2.1
—
—
—
0
0
146
1498
0.87
0.26
5.4
5.1
2.7
2.8
mmol/l
0.43
136
1380
41
371
1.14
0.25
4.1
3.7
0.0
0.0
estimate
0.00
13
121
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
50
1.21
0.20
1.0
1.8
—
—
—
0
0
6
52
1.16
0.19
1.2
1.2
—
—
—
0
0
6
52
1.16
0.19
1.2
1.2
—
—
—
0
0
7
85
0.82
0.15
1.1
1.4
—
—
—
0
0
144
1463
0.92
0.12
4.7
4.5
1.5
1.5
mmol/l
0.23
134
1347
5
62
0.80
0.08
1.4
1.3
—
—
—
0
0
11
122
0.90
0.07
1.7
1.6
—
—
—
0
0
10
90
1.12
0.05
4.3
2.7
1.2
1.2
mmol/l
—
10
72
141
1397
1.04
0.05
6.1
5.8
40.1
39.7
mmol/mol
0.18
130
1301
42
408
1.04
0.04
1.5
1.7
1.6
1.3
mmol/l
0.62
35
346
56
551
1.02
0.02
4.5
3.6
—
—
—
0
0
146
1453
1.02
0.01
5.1
4.7
5.8
5.9
mmol/l
0.27
137
1319
141
1404
1.02
0.00
4.3
4.1
1.3
1.2
mmol/l
0.04
131
1283
147
1473
0.99
0.00
4.8
4.6
4.7
4.7
mmol/l
0.13
138
1361
0
5
0.00
0.00
0.0
1.0
—
1937.8
—
0
5
7
75
0.93
0.00
1.1
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_RETROPERITONEUM_PERITONEUM_EXALLC – Benign neoplasm of soft tissue of retroperitoneum and peritoneum
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).